As depicted in Figures 7A–C regarding the differential expression levels of the three genes in clinical samples, the mRNA expression level of EPHB2 was significantly higher in CRC tissues than adjacent tissues (P < 0.05), whereas FCN3 and TINAG exhibited significantly reduced expression levels (both P < 0.05). The gene discussed is EPHB2; the disease is colorectal carcinoma.